Speaker: Catherine Draper, RDH, MS
Program Track: Clinical Practice
Course Description: The prevalence of HPV+ oropharyngeal cancer is increasing at an alarming rate. HPV+ oropharyngeal squamous cell carcinoma (HPV+) (OSSC) now comprises about 70% of cases of the disease diagnosed 2018 and is predicted to surpass the number of cases of cervical cancer by 2020. The new HPV+ OSSC patient is often younger, and male, with little or no alcohol or tobacco use history. Patients often present with more advanced neck disease and relatively small primary tumors. This program will provide participants with an overview of the global incidence of oropharyngeal cancer, the epidemiological role of the HPV 16 virus, key points for patient education, head and neck examination techniques, strategies for supporting patients during cancer therapy and opportunities for collaboration with other health care professionals. Current research and patient resources will be discussed as a means to support dental hygienists in their role as patient educators and oral health advocates.
- Describe the presentation and demographic profile of HPV+ oropharyngeal squamous cell cancers.
- Describe the components of an external and internal head and neck assessments/examination.
- Discuss the key features of patient education regarding HPV+ and HPV- oropharyngeal squamous cell carcinoma.
- Describe collaborative strategies for supporting patients undergoing treatment for oropharyngeal cancer.
CE Credit Hours: 2.0
Original Date of Session: 22 June 2019
The American Dental Hygienists' Association is designated as an approved provider by the American Academy of Dental Hygiene, Inc. #AADHADH (Jan. 1, 2020–Dec. 31, 2020). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.
The American Dental Hygienists’ Association is an approved provider of dental continuing education as recognized by the Dental Board of California, Provider #5238.